01 76McCarthy Tétrault
01 62261762
02 42342974
03 62476983
04 62477301
05 62537092
06 62687924
07 62687927
08 62688694
09 62688695
10 62688708
11 62688709
12 62741412
13 62741575
01 24LENALIDOMIDE
02 52Lenalidomide
01 24CAPSULE
02 52Capsule
01 42014-02-24
02 62017-07-24
03 62023-04-13
04 62023-05-16
05 542024-09-03
Patent Expiration Date : 2014-02-24
Date Granted : 2005-08-16
Brand Name : REVLIMID
Patent Number : 2342974
Filing Date : 1994-02-24
Strength per Unit : 10mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-02-24
Date Granted : 2005-08-16
Patent Expiration Date : 2017-07-24
Date Granted : 2008-06-17
Brand Name : REVLIMID
Patent Number : 2261762
Filing Date : 1997-07-24
Strength per Unit : 10mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-24
Date Granted : 2008-06-17
Patent Expiration Date : 2014-02-24
Date Granted : 2005-08-16
Brand Name : REVLIMID
Patent Number : 2342974
Filing Date : 1994-02-24
Strength per Unit : 5mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-02-24
Date Granted : 2005-08-16
Patent Expiration Date : 2017-07-24
Date Granted : 2008-06-17
Brand Name : REVLIMID
Patent Number : 2261762
Filing Date : 1997-07-24
Strength per Unit : 5mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-24
Date Granted : 2008-06-17
Patent Expiration Date : 2017-07-24
Date Granted : 2008-06-17
Brand Name : REVLIMID
Patent Number : 2261762
Filing Date : 1997-07-24
Strength per Unit : 15 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-24
Date Granted : 2008-06-17
Patent Expiration Date : 2014-02-24
Date Granted : 2005-08-16
Brand Name : REVLIMID
Patent Number : 2342974
Filing Date : 1994-02-24
Strength per Unit : 15 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-02-24
Date Granted : 2005-08-16
Patent Expiration Date : 2017-07-24
Date Granted : 2008-06-17
Brand Name : REVLIMID
Patent Number : 2261762
Filing Date : 1997-07-24
Strength per Unit : 25 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-24
Date Granted : 2008-06-17
Patent Expiration Date : 2014-02-24
Date Granted : 2005-08-16
Brand Name : REVLIMID
Patent Number : 2342974
Filing Date : 1994-02-24
Strength per Unit : 25 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-02-24
Date Granted : 2005-08-16
Patent Expiration Date : 2023-04-13
Date Granted : 2009-09-01
Brand Name : REVLIMID
Patent Number : 2477301
Filing Date : 2003-04-13
Strength per Unit : 10mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-13
Date Granted : 2009-09-01
Patent Expiration Date : 2024-09-03
Date Granted : 2012-05-29
Brand Name : REVLIMID
Patent Number : 2687927
Filing Date : 2004-09-03
Strength per Unit : 10mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-09-03
Date Granted : 2012-05-29
LOOKING FOR A SUPPLIER?
